Researchers Successfully Transplant Pig Kidneys After Sub-Zero Storage

Overcoming the Limits of Static Cold Storage

For decades, the transplant community has been constrained by the rapid degradation of organs once removed from a donor. Standard medical practice involves storing organs on ice at approximately 4°C (39°F). While this slows cellular decay, it provides only a narrow window of a few hours for surgeons to complete a transplant. Furthermore, direct freezing has historically been impossible because the resulting ice crystals cause irreversible damage to delicate cellular tissues.

Scientists have now developed a specialized device that maintains organs at -4°C (25°F) without triggering the formation of ice. By eliminating the risks associated with traditional freezing, this technology allows for the preservation of organs for several days, rather than hours. This development, characterized by researchers as a landmark achievement, was recently tested using pig kidneys, which were successfully transplanted after extended storage periods.

Advancements in Warm Perfusion Technology

Beyond sub-zero storage, innovations in organ transport are also targeting the “breathing” state of organs. UCLA Health reported the first transplant of donor lungs transported using a warm perfusion device —the Transmedics OCS — a device that circulates a plasma solution through the tissue. This method keeps lungs in a physiological state, addressing the common clinical problem of ischemia associated with static cold storage.

Dr. Abbas Ardehali, principal investigator for the FDA-approved clinical trial, emphasized that these updates allow clinicians to improve organ quality prior to surgery. Ardehali explained that being able to remove the extra fluid before a transplant has been one of the challenges in the field. The new system utilizes high osmotic pressure to draw fluid from the airways and includes a monitoring mode to continuously assess organ function during transit.

The Evolving Role of Xenotransplantation

These breakthroughs in preservation occur against a backdrop of increasing reliance on xenotransplantation—the use of animal organs in humans—to address the global shortage of human donors. While research into pig-to-human transplants has faced significant hurdles, including immune rejection and patient mortality, recent procedures have provided critical data.

Notable cases include the 2022 transplant of a genetically modified pig heart into David Bennett, who stated prior to the procedure that his only choice was either to die or to undergo the transplant.

Clinical Implications and Future Hurdles

If the ability to store organs in sub-zero conditions without ice becomes a standard, it could drastically expand the reach of donor networks, allowing organs to be transported across greater distances with higher viability. For now, the technology serves as a bridge, offering hope to millions of patients who currently remain on waiting lists for life-saving procedures.